AINDEX
Markets

Electromed, Inc. (ELMD)

ELMDAMEXBiotechnology: Electromedical & Electrotherapeutic Apparatus

$27.31

+0.2500 (+0.92%) today

Regular session, Nov 10, 1:25 PM ET

+0.92% 1D
Market cap
$226.32m
P/E
20.9
EPS, last 4 quarters
$1.31
Dividend yield
–
Day range
$27.07 to $27.71
52-week range
$23.01 to $47.40
Average volume
148.1k
Previous close
$27.06

Analysts

1 covering

Strong Buy1 buy, 0 hold, 0 sell

Targets a year out average $47.00, +72.1% from here

$47.00now $27.31$47.00

Earnings

Next report

Sep 2025

+13.6%

Dec 2025

+18.5%

Mar 2026

+34.6%

Jun 2026

+21.9%

estimate reported, and the surprise

Financials

QuarterSep 2025Dec 2025Mar 2026Jun 2026
Revenue$16.89m$18.90m$18.57m$19.42m
Gross profit$13.20m$14.82m$14.64m$15.28m
Operating income$2.67m$3.62m$3.77m$3.83m
Net income$2.14m$2.76m$3.00m$3.40m

Last four quarters: revenue $73.78m, margin 15.3%, free cash flow $8.41m

News

8 latest

The company

Electromed, Inc. manufactures, markets, and sells products that provide airway clearance therapy, including the SmartVest Airway Clearance System, to patients with compromised pulmonary function. It is headquartered in New Prague, Minnesota, and was founded in 1992. Further information about Electromed can be found at www.smartvest.com.

Sector
Health Care
Industry
Biotechnology: Electromedical & Electrotherapeutic Apparatus
Exchange
AMEX
Region
North America

Often looked at with it

Figures from Yahoo, Nasdaq (Zacks consensus) and Lighter. Stocks can be minutes behind. Nothing here is advice.